-
1
-
-
0026557720
-
Cefpirome versus ceftazidime in the treatment of urinary tract infections.
-
Cefpirome versus ceftazidime in the treatment of urinary tract infections. J Antimicrob Chemother. 1992.
-
(1992)
J Antimicrob Chemother
-
-
-
2
-
-
9244228530
-
Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, and prevention strategies: A consensus statement
-
Hospital-acquired pneumonia in adults diagnosis, assessment of severity, and prevention strategies: a consensus statement . Am J Respir Crit Care. 153:1995;1711-1725.
-
(1995)
Am J Respir Crit Care
, vol.153
, pp. 1711-1725
-
-
-
3
-
-
0027330399
-
The pharmacokinetics of cefpirome - Rationale for a twelve-hour dosing regimen.
-
Craig W.A. The pharmacokinetics of cefpirome - rationale for a twelve-hour dosing regimen. Scand J Infect Dis Suppl. 1993.
-
(1993)
Scand J Infect Dis Suppl
-
-
Craig, W.A.1
-
5
-
-
0031746493
-
Empiric therapy of bacterial infections in severe neutropenia.
-
Glauser M. Empiric therapy of bacterial infections in severe neutropenia. Diagn Microbiol Infect Dis. 1998.
-
(1998)
Diagn Microbiol Infect Dis
-
-
Glauser, M.1
-
6
-
-
0030741266
-
Respiratory tract infection: Epidemiology and surveillance.
-
Jacobs M.R. Respiratory tract infection epidemiology and surveillance. J Chemother. 1997.
-
(1997)
J Chemother
-
-
Jacobs, M.R.1
-
7
-
-
0028019448
-
The antimicrobial activity of cefotaxime: Comparative multinational hospital isolate surveys covering 15 years.
-
Jones R.N. The antimicrobial activity of cefotaxime comparative multinational hospital isolate surveys covering 15 years. Infection. 1994.
-
(1994)
Infection
-
-
Jones, R.N.1
-
8
-
-
0020182020
-
Cefotaxime: A review of in vitro antimicrobial properties and spectrum of activity.
-
Jones R.N., Thornsberry C. Cefotaxime a review of in vitro antimicrobial properties and spectrum of activity. Rev Infect Dis. 1982.
-
(1982)
Rev Infect Dis
-
-
Jones, R.N.1
Thornsberry, C.2
-
9
-
-
0028054242
-
Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. Study on the threat of emerging resistances: Real or perceived?
-
Jones R.N., Kehrberg E.N., Erwin M.E., Anderson S.G. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. Study on the threat of emerging resistances real or perceived? Diagn Microbiol Infect Dis. 1994.
-
(1994)
Diagn Microbiol Infect Dis
-
-
Jones, R.N.1
Kehrberg, E.N.2
Erwin, M.E.3
Anderson, S.G.4
-
10
-
-
0025773030
-
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6,000 recent clinical isolates from five medical centers.
-
Jones R.N., Pfaller M.A., Allen S.D., Gerlach E.H., Fuchs P.C., Aldridge K.E. Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6,000 recent clinical isolates from five medical centers. Diagn Microbiol Infect Dis. 1991.
-
(1991)
Diagn Microbiol Infect Dis
-
-
Jones, R.N.1
Pfaller, M.A.2
Allen, S.D.3
Gerlach, E.H.4
Fuchs, P.C.5
Aldridge, K.E.6
-
12
-
-
8544275076
-
Efficacy of cefpirome in patients with severe pneumonia
-
(1993) New Orleans, LA, abstract 934.
-
Legall JR, Leleu G, Orvain J, Sarkozy F (1993) (1993) Efficacy of cefpirome in patients with severe pneumonia. Proceedings and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, LA, abstract 934.
-
(1993)
Proceedings and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy
-
-
Legall, J.R.1
Leleu, G.2
Orvain, J.3
Sarkozy, F.4
-
14
-
-
0029401813
-
Laboratory assessment of antibacterial activity of zwitterionic 7-methoxyimino cephalosporins.
-
Pechère J.C., Wilson W., Neu H. Laboratory assessment of antibacterial activity of zwitterionic 7-methoxyimino cephalosporins. J Antimicrob Chemother. 1995.
-
(1995)
J Antimicrob Chemother
-
-
Pechère, J.C.1
Wilson, W.2
Neu, H.3
-
15
-
-
0027448985
-
A review of the adverse events profile of cefpirome.
-
Rubinstein E., Labs R., Reeves A. A review of the adverse events profile of cefpirome. Drug Saf. 1993.
-
(1993)
Drug Saf
-
-
Rubinstein, E.1
Labs, R.2
Reeves, A.3
-
16
-
-
0027746223
-
Penetration of cefpirome into sputum in chronic respiratory infections: Comparison of administration of 0.5 g and 1.0 g in the same patient.
-
Shishido H., Nagai H., Miyake S., Kaburagi T., Satoh K., Deguchi K. Penetration of cefpirome into sputum in chronic respiratory infections comparison of administration of 0.5 g and 1.0 g in the same patient. Int J Clin Pharmacol Res. 1993.
-
(1993)
Int J Clin Pharmacol Res
-
-
Shishido, H.1
Nagai, H.2
Miyake, S.3
Kaburagi, T.4
Satoh, K.5
Deguchi, K.6
-
17
-
-
0021963579
-
New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits.
-
Tauber M.G., Hackbarth C.J., Scott K.G., Rusnak M.G., Sandre M.A. New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits. Antimicrob Agents Chemother. 1985.
-
(1985)
Antimicrob Agents Chemother
-
-
Tauber, M.G.1
Hackbarth, C.J.2
Scott, K.G.3
Rusnak, M.G.4
Sandre, M.A.5
-
18
-
-
6844241938
-
Comparison of strategies using cefpirome and ceftazidime for empiric therapy of pneumonia in intensive care patients
-
Wolff M. Comparison of strategies using cefpirome and ceftazidime for empiric therapy of pneumonia in intensive care patients. Antimicrob Agents Chemother. 42:1998;28-36.
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 28-36
-
-
Wolff, M.1
|